BU08028 Displays a Promising Therapeutic Profile as an Analgesic in Monkeys

Keyphrases

• Buprenorphine 100%
• Analgesic 100%
• Monkey 100%
• Orphanin FQ 100%
• Nociceptin 100%
• Antinociception 75%
• Primates 50%
• μ-Opioid Receptor Agonist 50%
• Antinociceptive 50%
• μ-opioid Receptor 50%
• Progressive Ratio Schedule 25%
• Radio 25%
• Remifentanil 25%
• J-113397 25%
• Peptide Antagonist 25%
• Thermal Nociception 25%
• Reinforcing Effect 25%
• Systemic Administration 25%
• Binding Efficacy 25%
• Therapeutic Potential 25%
• Drug Self-administration 25%
• Bifunctional 25%
• Pharmacological Profile 25%
• Receptor Binding 25%
• Capsaicin 25%
• Naltrexone 25%
• Physiological Function 25%
• Binding Profile 25%
• Binding Affinity 25%
• Rhesus Monkey 25%
• Peptide Receptor 25%
• Peptide Agonist 25%
• Innovative Analgesics 25%
• Thermal Allodynia 25%
• Mu-opioid Receptor Antagonist 25%
• Respiration Activity 25%
• Cardiovascular Function 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Nociceptin 100%
• Haplorhini 100%
• Analgesic Agent 100%
• Buprenorphine 50%
• Antinociception 37%
• Opiate 25%
• Mu Opiate Receptor Agonist 25%
• Receptor 25%
• Remifentanil 12%
• Side Effect 12%
• Systemic Administration 12%
• Rhesus Monkey 12%
• Thermal Allodynia 12%
• Mu Opiate Receptor Antagonist 12%
• Naltrexone 12%
• Capsaicin 12%

Immunology and Microbiology

• Agonist 100%
• Haplorhini 100%
• Binding Affinity 33%
• Rhesus Monkey 33%
• Nociception 33%
• Receptor Binding 33%